The criticism of The Lancet, NEJM and JAMA is not new, but the health secretary may use his position to influence research ...

While the roots of weed prohibition have many unfortunate layers, storytelling played a huge role in negative public opinion around the plant.

McDermott gathered more than 100 health and life sciences innovators, investors, business leaders and advisers in Paris for our ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

The "One Big Beautiful Bill Act" includes negotiation exemptions for orphan drugs approved to treat more than one rare ...

There is a lot of macro "noise" in the market right now, as one Wall Street analyst called it, with higher tariffs, changes ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

For the Trump administration, pharmaceuticals are as much a national security issue as they are an issue of health or ...

The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for ...